Research In Cancer and Tumor
2013; 2(3): 49-56
doi:10.5923/j.rct.20130203.02
Ahu Izgi1, Armagan Gunal2, Ufuk Gunduz1
1Middle East Technical University, Department of Biological Sciences, Ankara, 06531, Turkey
2Gülhane Millitary Medical Academy, Department of Pathology, Ankara, 06010, Turkey
Correspondence to: Ahu Izgi, Middle East Technical University, Department of Biological Sciences, Ankara, 06531, Turkey.
Email: |
Copyright © 2012 Scientific & Academic Publishing. All Rights Reserved.
Introduction: Telomerase is a ribonucleoprotein synthesizing telomeric DNA onto the chromosomes which has two functional subunits: hTERT (humantelomerasereversetranscriptase) and hTR (humantelomeraseRNA). Activation of telomerase appears to be associated with unlimited replicative potential. Telomerase activity and expression of telomerase components may have significant roles in diagnosis or/and prognosis of malignancies. PCR-based TRAP assay is very sensitive for the detection of enzymatic activity of telomerase even if a few number of cancerous cells are available. The diagnostic or prognostic value of telomerase activity and its expression in colorectal cancer are still unclear. MaterialandMethods:Protein extraction was performed from specimens of matched normal and colon cancer specimens. Protein concetrations were determined by Bradford assay. Optimized protein concentrations were used for TRAPAssay (Telomericrepeatamplificationprotocol) which is a PCR-based assay. TRAP products were seperated by vertical gel electrophoresis on 12.5% polyacrylamide gel and visualized by silver staining. Gene expression of hTERT was determined by qPCR analysis.Results:The results demonstrated that all tumor tissues were telomerase positive whereas all corresponding normal tissues were telomerase negative. Among clinicopathological findings, telomerase activity was found to be associated with stage, histology, localization, distant metastasis and lymph node metastasis of tumor. The expression of hTERT was observed both in tumor and normal tissues, however; tumor tissues expressed 4.33 fold more hTERT than normal tissues. Although all of the clinicopathological findings differed in the expression of hTERT compared to normal tissues, they did not differ from each other significantly.Conclusion:Telomerase activity could be a promising tumor marker for colorectal cancer and there is a close association between the enzymatic activity and the expression of its catalytic subunit.
Keywords: Telomerase, Colorectal Cancer, hTERT
Cite this paper: Ahu Izgi, Armagan Gunal, Ufuk Gunduz, Significance of Telomerase Activity and Gene Expression in Colorectal Cancer, Research In Cancer and Tumor, Vol. 2 No. 3, 2013, pp. 49-56. doi: 10.5923/j.rct.20130203.02.
|
Figure 2. hTERT expression levels in different clinicopathological parameters (* Results were signifcant with a p<0.05, ** results with a p < 0.01 and *** results with a p<0.0001) |
[1] | van Steensel B, Smogorzewska A. & de Lange, T. TRF2 protects human telomeres from end‑to‑end fusions. Cell 1998; 92, 401–413. |
[2] | Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990 Aug 30;346 (6287):866-8. |
[3] | Watson J. D."Origin of concatemeric T7 DNA." Nat New Biol.1992; 239(94):197-201. |
[4] | Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CE, Harley CB and Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992 May; 11(5): 1921–1929 |
[5] | Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: casual or correlative. Nucleic Acids Res. 2007; 35(22): 7417–7428. |
[6] | Wright WE and Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 1992; 27,383-389 |
[7] | Brümmendorf TH. Telomerase Activity- a Prognostic Factor in Colorectal Cancer. Onkologie 2005; 28: 550-551 |
[8] | Theimer C& Feigon J. Structure and function of telomerase RNA. Current opinion in structural biology 2006; 16(3), 307-18. |
[9] | Blackburn EH. Telomere structure and synthesis. J Biol Chem.1990; 265, 5919-5921. |
[10] | Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955–9. |
[11] | Autexier C, & Lue NF. The Structure and Function of Telomerase Reverse Transcriptase. Annu Rev Biochem. 2006;(75), 493-517. |
[12] | Meeker AK, Coffey DS. Telomerase: a promising marker of biological immortality of germ, stem and cancer cells. A review, Biochemistry 1997; 62, 1323-31 |
[13] | Kim NW, Piatyszek M, Prowse KR, Harley CB, West MD. Ho PL, Coviello GM., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266 (5193), 2011-2015 |
[14] | Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med. 1995; 1(3):249-55. |
[15] | Ghori A, Usselmann B, Ferryman S, Morris A, Fraser I. Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer. Colorectal Disease 2000; 4(6), 441–446. |
[16] | Kawanishi-Tabata, R Lopez F, Fratantonio S, Kim N, Goldblum J, Tubbs R, Elson P, et al. Telomerase activity in stage II colorectal carcinoma. Cancer 2002; 95(9), 1834-9. |
[17] | Roig AL, Wright WE, & Shay JW. Is Telomerase a Novel Target for Metastatic Colon Cancer, Current Colorectal Cancer Reports 2009; 5: 203–208 |
[18] | Livak KJ, Schmitthen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(Delta Delta C(T)) Methods 2001;25(4), 402-408. |
[19] | Chadeneau C, Hay K , Hirte H, Gallinger S, Bacchetti S. (1995) Advances in Brief Telomerase Activity Associated with Acquisition of Malignancy in Human Colorectal Cancer. Medicine, 2533-2536. |
[20] | Smith R, Lam A, K-Y Telomerase Activity: Detection and Clinical Implications in human cancers. Clinical oncology and search 2009; 2009-24614. |
[21] | Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000; 25: 169-193. |
[22] | Fang DC, Joanne Y, Luo Y, et al. Detection of telomerase activity in biopsy samples of colorectal cancer. J Gastroenterol Hepatol. 1999; 14, 328-332. |
[23] | Yan P, Saraga EP, Bouzourene H, et al. Telomerase activation in colorectal cacinogenesis. J Pathol.1999; 189: 207-12. |
[24] | Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek M.A and ShaJ W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med.1995; (1), 249-255 |
[25] | Hiyama E,Yokoyama T,Tatsumoto N, Hiyama K, Imamura Y,Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y.Telomerase activity in gastric cancer. Cancer Res.1995; (55), 3258-3262. |
[26] | Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M. Telomerase activity in gynecological tumors. Clin. Cancer Res. 1996; (2); 2023-2028. |
[27] | Roig AI, Wright, W. E, & Shay J W. Is Telomerase a Novel Target for Metastatic Colon Cancer, Current Colorectal Cancer Reports 2009; 5, 203–208. |
[28] | Ghori A, Usselmann B, Ferryman S, Morris A, Fraser I.(2000). Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer. Colorectal Disease 4(6), 441–446. |
[29] | Yan, P, & Bosman, F. T. (1998). Diagnostic Techniques Tissue Quality is an Important Determinant of Telomerase Activity as Measured by TRAP Assay. Biotechniques, 25(4), 660-662. |
[30] | Tang R, Cheng, a J, Wang, J. Y& Wang T C. (1998). Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer research, 58(18), 4052-4. |
[31] | Glebov OK, Rodriguez LM, Nakahara K, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003; 12:755–62. |
[32] | Engelhardt M, Drullinsky P, Guillem J, & Moore Ma. (1997). Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 3(11), 1931-41. |
[33] | Ghori A, Usselmann B, Ferryman S, Morris A, Fraser I.(2000). Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer. Colorectal Disease 4(6), 441–446. |
[34] | Saito Y, Kosugi S, Wakabayashi Y, Mishima Y, Hatakeyama K, Kominami R (1997)Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues, Jpn J Cancer Res, 88(8)-732-7. |
[35] | Shoji Y, Yoshinaga K, Inoue A, Iwasaki A, Sugihara K 2000. Quantification of telomerase activity in sporadic colorectal carcinoma. Cancer 88(6), 1304–1309. |
[36] | Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, et al. (2002). Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 95(10), 2103-11. |
[37] | Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, Esposito G, DelBianco P, et al. (2008). Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clinical cancer research: an official journal of the American Association for Cancer Research, 14(22), 7444-51. |
[38] | Kilian A, Bowtell D.D.L. and Abud H.E. (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex slicing patterns in different cell types. Hum. Mol. Genet., 6, 2011–2019. |
[39] | Yi X, White D.M, Aisner D.L, Baur J.A, Wright W.E, Shay J.W (2000) An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity. Neoplasia 2(5): 433–440. |
[40] | Reddel RR, Bryan TM, Colgin LM, Perrem KT and Yeager TR. Alternative lengthening of telomeres in human cells. Radiat Res. 2001; 155: 194-200. |
[41] | Zhong Z, Shiue L, Kaplan S & de Lange, T. (1992). A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol. Cell. Biol. 13, 4834-4844. |
[42] | Kirkpatrick KL, Mokbel K.(2001). The significance of human telomerase reverse transcriptase (hTERT).EJSO. 27: 754-760. |